The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery/indefinite-quantity contract to Bioqual, Inc. valued at $545 million with a period of performance from September 2021 to August 2028. Task orders issued against the contract include a $2,000 firm fixed price order to Bioqual for comprehensive and rapid response services in Bethesda, Maryland from September 2021 to August 2022. The original solicitation sought proposals for a...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The National Institute of Allergy and Infectious Diseases awarded a single award Indefinite Delivery Contract to Booz Allen Hamilton Inc. with a potential value of $545,452,906 to provide comprehensive and rapid response services supporting NIAID's research programs through August 2028. A $2,000 firm fixed price delivery order was also awarded against the contract for unspecified Task Area D services in Bethesda, Maryland from September 2021 through August 2022. The original solicitation...
The National Institute of Allergy and Infectious Diseases awarded a single award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, with a potential value of $545,452,906 and period of performance from September 1, 2021 through August 31, 2028. The contract provides comprehensive and rapid response services to support NIAID's research programs including clinical trials, manufacturing, nonclinical studies, analytics, and basic research. A $2,000 firm fixed...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $102.5 million Indefinite Delivery Contract to Battelle Memorial Institute to provide research, development, testing, and evaluation services for vaccines and other biologics for infectious diseases. Under this contract, Battelle has been issued numerous cost-plus-fixed-fee and cost-plus-award-fee delivery orders to support NIAID's programs....
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to Leidos, Inc. operating as Saic to provide comprehensive and rapid response services supporting research programs. With a potential value of $545,452,906 over seven years ending August 2028, the multiple award contract vehicle enables delivery orders for clinical trials, manufacturing, animal studies, analytics, storage, and basic research. Leidos was issued an...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
This single-award Indefinite Delivery Contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide pre-clinical models of infectious diseases. The $146.3 million, 7-year contract has a completion date of July 14, 2031 and was awarded on July 15, 2024. The contract aims to develop and employ animal and...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded this $112 million Indefinite Delivery Contract to Battelle Memorial Institute, a large nonprofit research and development organization, for "Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases." The contract provides a comprehensive suite of preclinical, nonclinical, and clinical testing services to...